Thrombocytopenia in Patients with Chronic Hepatitis C Virus Infection - Wikidata - awgldk - TriplyDB

Thrombocytopenia in Patients with Chronic Hepatitis C Virus Infection

Thrombocytopenia in Patients with Chronic Hepatitis C Virus Infection

http://www.wikidata.org/entity/Q33440130

about

Cardiac Toxicity Associated with HCV Direct Antiviral Agents

P2860

Q58701131-34C0CF58-AEE5-4C9C-AC75-B3EBC11FF000

P2860

Thrombocytopenia in Patients with Chronic Hepatitis C Virus Infection

http://www.wikidata.org/entity/Q33440130

description

2017 nî lūn-bûn

@nan

2017 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի մարտին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Thrombocytopenia in Patients with Chronic Hepatitis C Virus Infection

@ast

Thrombocytopenia in Patients with Chronic Hepatitis C Virus Infection

@en

type

label

Thrombocytopenia in Patients with Chronic Hepatitis C Virus Infection

@ast

Thrombocytopenia in Patients with Chronic Hepatitis C Virus Infection

@en

prefLabel

Thrombocytopenia in Patients with Chronic Hepatitis C Virus Infection

@ast

Thrombocytopenia in Patients with Chronic Hepatitis C Virus Infection

@en

P1433

Q33440130-F6BBC18B-DC09-41DA-8700-0A2B685EE06C

P1476

Q33440130-0B84714B-0B39-4F6C-94D5-D265F3F4642E

P2093

Q33440130-0216E3B1-69D7-44F5-8D13-2742D550B075

Q33440130-9BB73ED4-780A-4609-9285-BC598E383F05

Q33440130-B68E2BCC-11F5-4C34-BA91-239A650B3C51

Q33440130-B69C12AE-D188-4AD8-A396-2FF8B78F7DAB

P2860

Q33440130-0023BCF1-CA26-4AC2-BF5C-604055728C5B

Q33440130-00D882EB-A8C3-47EA-B637-B850B94D9487

Q33440130-02DD7BA0-A131-4223-98F8-F1786A00B08F

Q33440130-02EA2213-AC59-40F8-80DF-08D105ADA629

Q33440130-03CA69BF-D3B6-4084-AB79-3D0603BFBC63

Q33440130-05EB0D19-3B12-47C2-AAB0-46D5AA209DF0

Q33440130-0B3BEF8A-CADB-4454-8D25-F5A5AD601B77

Q33440130-0C594E0F-F5EE-49C3-84C2-287978D72159

Q33440130-11EC4CC3-9728-4B97-9EF6-8D43BAA877AF

Q33440130-1212F140-44C6-49A2-8504-0E6A7FC6877F

P304

Q33440130-9EA5A2F3-257D-41AB-8C6E-4B4E6ADA67D1

P31

Q33440130-C8AC0885-A9DB-4477-9016-33A28C0B5D44

P356

Q33440130-6B49FB09-7053-46B4-A11B-4E4EF0C8A66F

P433

Q33440130-0F4341DE-0DAF-4627-B61C-9DDC7039A61C

P478

Q33440130-1AA0BE23-A995-46F7-A97F-9F846C085A2B

P50

Q33440130-16C27B31-7F2F-487C-9BF1-DF5E8CF9DCCD

Q33440130-98BA0BB4-F026-4573-9B9D-9D10AFFC1708

P577

Q33440130-83A3F115-D4E8-4690-9297-E1B9FD9C94C1

P698

Q33440130-9E0968EC-70DA-4992-82D9-5DF3D0E24AD1

P921

Q33440130-2FCEB7E8-AFEB-406C-88FF-1925F29DB978

P932

Q33440130-48298BFE-E3FD-4E61-893F-E644E1F64CE8

P356

P1433

Mediterranean journal of hematology and infectious diseases

P1476

Thrombocytopenia in Patients with Chronic Hepatitis C Virus Infection

@en

P2093

Nabin Khanal

http://www.w3.org/2001/XMLSchema#string

Prajwal Dhakal

http://www.w3.org/2001/XMLSchema#string

Rashmi Banjade

http://www.w3.org/2001/XMLSchema#string

Smrity Upadhyay

http://www.w3.org/2001/XMLSchema#string

P2860

The prevalence of hepatitis C virus infection in the United States, 1999 through 2002

Hematopoietic growth factor mimetics.

Peptide agonists of the thrombopoietin receptor.

Immunogenicity of thrombopoietin mimetic peptide GW395058 in BALB/c mice and New Zealand white rabbits: evaluation of the potential for thrombopoietin neutralizing antibody production in man.

Factors associated with positive predictability of the anti-HCV ELISA method with confirmatory RT-PCR.

Increased incidence of anti-cardiolipin antibodies in patients with hepatitis C is not associated with aetiopathogenetic link to anti-phospholipid syndrome.

Anticardiolipin antibodies in patients with chronic hepatitis C virus infection: characterization in relation to antiphospholipid syndrome

Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology.

Hepatic fibrosis plays a central role in the pathogenesis of thrombocytopenia in patients with chronic viral hepatitis.

Thrombocytopenia caused by the development of antibodies to thrombopoietin.

P304

e2017019

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4084/MJHID.2017.019

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Vijaya Raj Bhatt

P577

2017-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28293407

http://www.w3.org/2001/XMLSchema#string

P921

thrombocytopenia

P932

5333732

http://www.w3.org/2001/XMLSchema#string